13D/13G Filings - Taysha Gene Therapies Inc. (TSHA)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-14
09:00 am
Sale
2024-12-3113GTaysha Gene Therapies, Inc.
TSHA
RTW Investments, LP12,368,334
5.900%
-6,137,222decrease
(-33.16%)
Filing
History
2025-02-12
09:22 am
Sale
2024-12-3113GTaysha Gene Therapies, Inc.
TSHA
FMR LLC16,365,664
8.000%
-2,312,862decrease
(-12.38%)
Filing
History
2025-02-05
6:05 pm
Purchase
2024-12-3113GTaysha Gene Therapies, Inc.
TSHA
Octagon Capital Advisors LP10,450,000
5.100%
10,450,000increase
(New Position)
Filing
History
2025-02-05
10:43 am
Purchase
2024-12-3113GTaysha Gene Therapies, Inc.
TSHA
MORGAN STANLEY
MS
17,629,264
8.600%
17,629,264increase
(New Position)
Filing
History
2024-11-14
5:51 pm
Sale
2024-09-3013GTaysha Gene Therapies, Inc.
TSHA
Venrock Healthcare Capital Partners III, L.P.9,000,000
4.400%
-1,412,872decrease
(-13.57%)
Filing
History
2024-11-14
5:46 pm
Purchase
2024-09-3013GTaysha Gene Therapies, Inc.
TSHA
RA CAPITAL MANAGEMENT L.P.21,539,465
9.990%
2,869,376increase
(+15.37%)
Filing
History
2024-11-14
09:40 am
Purchase
2024-09-3013GTaysha Gene Therapies, Inc.
TSHA
Avoro Capital Advisors LLC23,094,444
9.990%
23,094,444increase
(New Position)
Filing
History
2024-11-12
10:34 am
Sale
2024-11-0813GTaysha Gene Therapies, Inc.
TSHA
FMR LLC18,678,526
9.113%
-3,760,598decrease
(-16.76%)
Filing
History
2024-11-08
2:17 pm
Unchanged
2024-09-3013GTaysha Gene Therapies, Inc.
TSHA
BlackRock Inc.
BLK
13,520,533
6.600%
0
(Unchanged)
Filing
History
2024-10-22
6:06 pm
Purchase
2024-09-3013GTaysha Gene Therapies, Inc.
TSHA
BlackRock Inc.
BLK
13,520,533
6.600%
12,474,043increase
(+1191.99%)
Filing
History
2024-02-14
8:44 pm
Sale
2023-12-3113GTaysha Gene Therapies, Inc.
TSHA
Venrock Healthcare Capital Partners III, L.P.10,412,872
5.600%
-4,031,572decrease
(-27.91%)
Filing
History
2024-02-14
5:01 pm
Sale
2023-12-3113GTaysha Gene Therapies, Inc.
TSHA
RA CAPITAL MANAGEMENT L.P.18,670,089
9.990%
-20,779decrease
(-0.11%)
Filing
History
2024-02-14
07:08 am
Purchase
2023-12-3113GTaysha Gene Therapies, Inc.
TSHA
RTW Investments, LP18,505,556
9.800%
18,505,556increase
(New Position)
Filing
History
2024-02-09
4:24 pm
Sale
2023-12-3113GTaysha Gene Therapies, Inc.
TSHA
TCG Crossover GP I, LLC2,912,861
1.600%
-8,198,250decrease
(-73.78%)
Filing
History
2024-02-09
09:49 am
Sale
2024-02-0813GTaysha Gene Therapies, Inc.
TSHA
FMR LLC22,439,124
12.002%
-5,534,422decrease
(-19.78%)
Filing
History
2023-09-11
08:23 am
Purchase
2023-09-0813GTaysha Gene Therapies, Inc.
TSHA
FMR LLC27,973,546
14.962%
24,768,624increase
(+772.83%)
Filing
History
2023-08-28
4:16 pm
Purchase
2023-08-1613GTaysha Gene Therapies, Inc.
TSHA
Venrock Healthcare Capital Partners III, L.P.14,444,444
7.700%
14,444,444increase
(New Position)
Filing
History
2023-08-25
5:01 pm
Purchase
2023-08-1613GTaysha Gene Therapies, Inc.
TSHA
RA CAPITAL MANAGEMENT L.P.18,690,868
9.990%
18,690,868increase
(New Position)
Filing
History
2023-08-25
4:22 pm
Purchase
2023-08-1613GTaysha Gene Therapies, Inc.
TSHA
TCG Crossover GP I, LLC11,111,111
5.900%
11,111,111increase
(New Position)
Filing
History
2023-08-21
4:01 pm
Purchase
2023-08-1613DTaysha Gene Therapies, Inc.
TSHA
Manning Paul B23,476,333
12.600%
16,486,472increase
(+235.86%)
Filing
History
Goto 0, 1, Next